VIA Pharmaceuticals, Inc. and Corautus Genetics Inc. (VEGF) Complete Merger to Form VIA Pharmaceuticals, Inc.
6/6/2007 1:24:36 PM
More...
|
Corautus Genetics Inc. (VEGF) Stockholders Approve Merger with VIA Pharmaceuticals, Inc. and Related Proposals
6/5/2007 1:07:28 PM
More...
|
Corautus Genetics Inc. (VEGF) Receives Nasdaq Additional Deficiency Notice
5/30/2007 1:04:28 PM
More...
|
VIA Pharmaceuticals, Inc. Names Richard Anderson, Mark Bagnall and David Howard as Director Nominees for Combined Company Following Corautus Genetics Inc. (VEGF) Merger
5/25/2007 3:09:26 AM
More...
|
Corautus Genetics Inc. (VEGF) And VIA Pharmaceuticals, Inc. Announce Merger Agreement
2/8/2007 11:42:11 AM
More...
|
Corautus Genetics Inc. (VEGF) Announces Discussions Regarding A Potential Business Combination With A Privately-Held Biotech Company
1/17/2007 12:45:15 PM
More...
|
Corautus Genetics Inc. (VEGF) Receives Determination Letter From Nasdaq Regarding Continued Listing
12/15/2006 10:11:02 AM
More...
|
Corautus Genetics Inc. (VEGF) Reports Third Quarter Financial Results
11/14/2006 11:57:33 AM
More...
|
Corautus Genetics Inc. (VEGF) Announces Redirection Of Focus And Transition Of Officers; No Further Clinical Trials For VEGF-2
11/6/2006 12:46:21 PM
More...
|
The Day In Review: Genentech, Inc. (DNA) Hits Its Numbers
10/10/2006 5:08:06 PM
More...
|
|